Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07414368Enrolling by invitation
StimLabs umbilical cord material for wound healing
This study looks at how a wound treatment made from donated human umbilical cord tissue works for both new and long-lasting wounds. The treatment is a dehydrated powder that is applied directly to the wound.
Bridgeport, ConnecticutAges 18 years+ - NCT07413939RecruitingPhase 2/Phase 3
Study of RO7771950 vs tucatinib for HER2-positive breast cancer
This trial tests a new drug, RO7771950, against another drug called tucatinib. Both are given with standard chemotherapy to see which works better for advanced breast cancer that is HER2-positive. People with brain metastases may join.
Huntsville, AlabamaAges 18 years+ - NCT07410637Recruiting
Thyroid hormones and energy in graves' or thyroid cancer
This trial studies how thyroid hormone levels affect your body's use of sugar and energy. It may help people newly diagnosed with Graves' disease or thyroid cancer understand their metabolism better.
Ulm, Baden-WurttembergAges Any age - NCT07407569RecruitingPhase 2
HPV vaccine study for women with HPV16
This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.
Antwerp, WilrijkAges 18–45 - NCT07414849Recruiting
Amniotic membrane to prevent mesh exposure after vaginal surgery
This trial tests if placing a human amniotic membrane over surgical mesh during vaginal repair for pelvic organ prolapse can reduce the risk of the mesh pushing through the vaginal tissue. The study is for women who have not had a hysterectomy and may also have stress urinary incontinence.
Buenos AiresAges Any age - NCT07399028Recruiting
Skin changes from biostimulator treatment in women
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
New York, New YorkAges 45–65 - NCT05104515RecruitingPhase 1
First cancer vaccine test for advanced lung, ovarian, or prostate cancer
This Phase 1 study tests OVM-200, a new cancer vaccine, to see how it is tolerated and how it affects the immune system in people with advanced NSCLC, ovarian cancer, or prostate cancer. You may be eligible if your cancer has already had approved treatment(s) and no further standard options are planned within the first two months.
London, LondonAges 18–75 - NCT07400341RecruitingPhase 2
Romiplostim vs rhTPO for platelet recovery after transplant
This trial compares two drugs, romiplostim and rhTPO, to help increase platelet counts after a stem cell transplant in people with MDS or aplastic anemia. The goal is to see which drug works better at reducing the need for platelet transfusions.
Suzhou, JiangsuAges 18–65 - NCT07406022Recruiting
Light-based imaging to help diagnose skin cancer
This study uses special cameras and light to look at skin growths and help doctors diagnose skin cancer. It may be a way to better understand your skin without taking a sample.
MetzAges 18 years+ - NCT07405346Enrolling by invitation
Organoid-guided treatment for advanced leiomyosarcoma
This trial uses your tumor's lab-grown organoids to find the most effective personalized treatment for advanced leiomyosarcoma. It aims to match you with a drug that targets your specific cancer.
Wuhan, HubeiAges 18–75 - NCT07402928Recruiting
Dopamine signals in health and Parkinson's
This study uses MRI scans to look at dopamine signals in the brain. The goal is to understand how Parkinson's affects these signals.
HvidovreAges 35 years+ - NCT06827249Recruiting
Testing peginterferon for RSV lung infection in young children
This trial tests a medication called peginterferon to treat RSV bronchiolitis (a lung infection causing wheezing and breathing trouble) in children ages 6 months to 2 years. It aims to see if the drug helps them recover faster.
Wuhan, HubeiAges 6 months–2 years - NCT07393841Recruiting
Fitness markers study with exercise and blood test
This study looks at different markers of fitness in your blood and body. You will do a maximal exercise test on a bike or treadmill, give a blood sample, and fill out some questionnaires to help researchers understand overall health.
New Haven, ConnecticutAges 18 years+ - NCT07390175Recruiting
New heart-ablation method for long-lasting arrhythmias
This study tests a new way to destroy the tissue causing dangerous heart rhythms using a detailed model of how the heart's electrical signals spread. It may be an option for people with long-lasting atrial fibrillation or hard-to-control ventricular arrhythmias who are already scheduled for a standard ablation procedure.
Madrid, MadridAges 18 years+ - NCT07397455RecruitingPhase 1
COVID-19 Omicron Human Challenge Study
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
LondonAges 18–50 - NCT07396181Recruiting
Standardizing embryo transfer conditions for IVF
This study compares different methods for transferring frozen embryos into the uterus during IVF. It aims to find the best technique to improve pregnancy chances.
WarsawAges 18–38 - NCT07397819RecruitingPhase 1/Phase 2
Liposomal Irinotecan for Malignant Ascites
This trial tests a drug called liposomal irinotecan, given alone or with other medications, to treat fluid buildup in the belly caused by digestive system cancers. It's for people who have already tried standard treatments without success.
Guangzhou, GuangdongAges 18 years+ - NCT06697964Recruiting
High resolution anuscopy study
This trial is studying high-resolution anuscopy (a detailed exam of the anal area) in people who are referred for this procedure. It aims to learn more about the findings and help improve care.
JetteAges 18 years+ - NCT06715384Recruiting
Testing a new camera tool to measure colon polyps
This trial tests a computer-assisted measurement system during a colonoscopy to see if it can more accurately measure polyps. You might consider this if you are scheduled for a routine colonoscopy for screening or monitoring.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07383441RecruitingPhase 3
Adding Biotherapy or Placebo to Standard Kidney Cancer Treatment
This trial tests whether adding a biotherapy (a special drug from a living source) or a placebo to standard treatments helps people with advanced kidney cancer. It may be a good option if your cancer hasn't been treated yet and you are in fairly good health.
Fayetteville, ArkansasAges 18 years+ - NCT07384715RecruitingPhase 1
GEN3018 for AML or high-risk MDS
This trial tests a new drug called GEN3018 for people with acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. It aims to see if the drug is safe and effective.
AarhusAges 18 years+ - NCT07380204Recruiting
Measuring Hsp90 in the brain with a PET scan
This study uses a special PET scan to measure a protein called Hsp90 in the brain. It aims to understand how Hsp90 levels differ in healthy people and those with Parkinson's, Alzheimer's, or ALS, which may lead to new treatments.
Leuven, Vlaam-BrabantAges 18–70 - NCT06839495Recruiting
Oocyte elasticity and embryo development in IVF
This study looks at how the thickness and flexibility of the outer layer of a woman's egg (called the zona pellucida) relates to whether the egg develops into a high-quality embryo (a blastocyst). It may help improve embryo selection during IVF treatment.
TaichungAges Up to 38 years - NCT05818410Recruiting
Brain and tech training after below-knee leg loss
This study looks at how your brain works with assistive technology after losing a leg below the knee. It may help researchers improve how prosthetic devices feel and function by measuring brain and movement signals during training.
BrusselsAges 18–65
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.